INS and Alzheimer disease: Epidemiologic studies in the elderly, as well as experimental investigations in humans and animal models, have consistently suggested that lower brain glucose uptake and dysfunctional brain insulin signaling, termed as “brain insulin resistance” promote and accelerate cognitive dysfunction and AD progression [19].